APOTEX INC.

In News

Apotex licenses exclusive Canadian rights to testosterone replacement therapy Nebido® from Grünenthal - PR Newswire

PR Newswire - Feb 05, 2026

Apotex Expands Men’s Health Portfolio With Nebido License - Mexico Business News

Mexico Business News - Feb 06, 2026

Apotex receives Health Canada approval for Aflivu™, a biosimilar to Eylea®, available in pre-filled syringe and vial formats - Yahoo! Finance Canada

Yahoo! Finance Canada - Jul 02, 2025

Axsome Sues Apotex to Block Copies of Symbravo Migraine Drug - Bloomberg Law News

Bloomberg Law News - Sep 29, 2025

Hawaii customers urged to register for compensation in settlement with generic drug manufacturer - Hawaii News Now

Hawaii News Now - Aug 20, 2025

State AGs Want Final OK For $39M Apotex Price-Fixing Deal - Law360

Law360 - Aug 06, 2025

Apotex Receives Health Canada Approval for LOQTORZI® -- The First and Only Immuno-Therapy for Recurrent Unresectable or Metastatic Nasopharyngeal Cancer - PR Newswire

PR Newswire - Oct 23, 2025

Apotex introduces IVRA™ (Melphalan) hydrochloride injection: First ready to dilute liquid formulation of Melphalan injection approved via 505(b)(2) NDA in the United States - BioSpace

BioSpace - May 09, 2025

Nearly 200,000 Eye Drop Products Have Been Recalled Nationwide - The Healthy @Reader's Digest

The Healthy @Reader's Digest - Jul 04, 2025

Apotex Follows Biocon With Canadian Biosimilar Aflibercept Launch - Citeline News & Insights

Citeline News & Insights - Jul 07, 2025

Apotex Strengthens Commitment to Women's Health with Exclusive Canadian Rights to "Linzagolix" for Uterine Fibroid Treatment - PR Newswire

PR Newswire - Oct 07, 2025

New Incyte Suit Targets Broader Apotex Bid to Sell Jakafi Rival - Bloomberg Law News

Bloomberg Law News - May 09, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment